Induced Pluripotent Stem Cell Market Share, Size, Trends, Industry Analysis Report, By Derived Cell; By Workflow; By Application; By Region; Segment Forecast, 2024

Description

List of Tables

The global Induced Pluripotent Stem Cell (iPSC) market size is expected to reach USD 4,355.56 Million by 2032, according to a new study by Polaris Market Research. The report "iPSC Market Share, Size, Trends, Industry Analysis Report, By Derived Cell (Hepatocytes, Fibroblasts, Neural Cells, Amniotic Cells, Cardiomyocytes, Others); By Workflow; By Application; By Region; Segment Forecast, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The growing elderly population, rising cases of chronic diseases, and advancements in research and development are contributing to the increasing growth of the iPSC market. This growth is attracting significant investments from pharmaceutical companies worldwide, who are interested in advanced drug development and testing, and is thereby catering to the overall growth of the iPSC market.

The overall stem cell workflow, although complex, presents a unique opportunity for new entrants in the production of iPSC. Some of the critical and complex processes involved in the production of iPSC include generation, reprogramming, and differentiation into various desired cell types, which require both expertise and resources. However, with the option of commercial iPSC-derived cell purchase or outsourcing programming, new entrants are encouraged to explore this field and contribute to its growth.

With several market entry options available, several trends are observed, such as concentrated efforts on reprogramming and in-house differentiation, purchase of iPSC-derived cell types from off-the-shelf product portfolios, or entering into agreements with third-party purveyors to produce customized models. This trend has spurred a range of possibilities that will feature iPSC-based models for a host of disease models, phenotypic assays, and toxicology testing.

Biopharmaceuticals are drugs that are derived from microbiological sources such as hormones, vaccines, monoclonal antibodies, therapeutic enzymes, blood factors, and so on. These drugs are highly specific and have opened up new avenues in healthcare, such as personalized medicine. This approach involves treating various diseases or conditions using specific biomolecules depending on the patient's physiological, biological, and genetic makeup. As conventional pharmaceuticals have limited applicability and there are few players in the biotechnology industry, the growth of cell culture technology has been fueled.

iPSC Market Report Highlights

In 2023, the global market witnessed significant growth, with cardiomyocytes emerging as the dominant segment. This is because cardiomyocytes, specialized muscle cells in the heart responsible for its contraction and pumping action, have gained significant attention due to their potential for therapeutic applications.

The regenerative medicine industry is projected to experience a substantial growth rate in the upcoming years. Regenerative medicine involves therapeutic techniques that target the repair, replacement, or regeneration of tissues or organs in order to restore normal function in individuals who are suffering from injury or disease.

The North American region dominated the global market, owing to its extensive research and innovation in the field of biomedical science.

The global key market players include Astellas Pharma Inc., Axol Bioscience Ltd., Cynata Therapeutics Limited, Fate Therapeutics, FUJIFILM Holdings Corporation (Cellular Dynamics), Ncardia, REPROCELL Inc., Takara Bio Inc., Thermo Fisher Scientific Inc., ViaCyte, Inc, etc.

Polaris Market Research has segmented the iPSC market report based on derived cell, workflow, application, and region:

iPSC, Derived Cell Outlook (Revenue - USD Million, 2019 - 2032)

Hepatocytes
Fibroblasts
Neural Cells
Excitatory Neurons
Inhibitory Neurons
Amniotic Cells
Cardiomyocytes
Others

iPSC, Workflow Outlook (Revenue - USD Million, 2019 - 2032)

Reprogramming
Cell Culture
Cell Characterization / Analysis
Engineering
Others

iPSC, Application Outlook (Revenue - USD Million, 2019 - 2032)

Manufacturing
Academic Research
Drug Development & Discovery
Toxicity Screening
Regenerative Medicine

iPSC, Regional Outlook (Revenue - USD Million, 2019 - 2032)

North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
Austria
Netherlands
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Indonesia
Malaysia
Australia
Rest of APAC
Latin America
Argentina
Brazil
Mexico
Rest of Latin America
Middle East & Africa
UAE
Saudi Arabia
Israel
South Africa
Rest of MEA

Product Code: PM2014

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources

4. Global Induced Pluripotent Stem Cell (iPSC) Market Insights

4.1. Induced Pluripotent Stem Cell (iPSC) Market - Workflow Snapshot
4.2. Induced Pluripotent Stem Cell (iPSC) Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Increasing demand for body reconstruction procedures and tissue engineering
  - 4.2.1.2. Rising Demand for Vaccine Production, Artificial Organs, Media, and Biopharmaceuticals
- 4.2.2. Restraints and Challenges
  - 4.2.2.1 Ethical Concerns Pertaining to Animals
- 4.2.3 Porter's Five Forces Analysis
  - 4.2.3.1. Bargaining Power of Suppliers (Moderate)
  - 4.2.3.2. Threats of New Entrants: (Low)
  - 4.2.3.3. Bargaining Power of Buyers (Moderate)
  - 4.2.3.4. Threat of Substitute (Moderate)
  - 4.2.3.5 Rivalry among existing firms (High)
4.3. PESTEL Analysis
4.4. Induced Pluripotent Stem Cell (iPSC) Market Workflow Trends
4.5. Value Chain Analysis
4.6. COVID-19 Impact Analysis

5. Global Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
5.3. Hepatocytes
- 5.3.1. Global Induced Pluripotent Stem Cell (iPSC) Market, by Hepatocytes, by Region, 2019-2032 (USD Million)
5.4. Fibroblasts
- 5.4.1. Global Induced Pluripotent Stem Cell (iPSC) Market, by Fibroblasts, by Region, 2019-2032 (USD Million)
5.5. Neural Cells
- 5.5.1. Global Induced Pluripotent Stem Cell (iPSC) Market, by Neural Cells, by Region, 2019-2032 (USD Million)
- 5.5.2. Excitatory Neurons
  - 5.5.2.1. Global Induced Pluripotent Stem Cell (iPSC) Market, by Excitatory Neurons, by Region, 2019-2032 (USD Million)
- 5.5.3. Inhibitory Neurons
  - 5.5.3.1. Global Induced Pluripotent Stem Cell (iPSC) Market, by Inhibitory Neurons, by Region, 2019-2032 (USD Million)
5.6. Amniotic Cells
- 5.6.1. Global Induced Pluripotent Stem Cell (iPSC) Market, by Amniotic Cells, by Region, 2019-2032 (USD Million)
5.7. Cardiomyocytes
- 5.7.1. Global Induced Pluripotent Stem Cell (iPSC) Market, by Cardiomyocytes, by Region, 2019-2032 (USD Million)
5.8. Others
- 5.8.1. Global Induced Pluripotent Stem Cell (iPSC) Market, by Others, by Region, 2019-2032 (USD Million)

6. Global Induced Pluripotent Stem Cell (iPSC) Market, by Application

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
6.3. Manufacturing
- 6.3.1. Global Induced Pluripotent Stem Cell (iPSC) Market, by Manufacturing, by Region, 2019-2032 (USD Million)
6.4. Academic Research
- 6.4.1. Global Induced Pluripotent Stem Cell (iPSC) Market, by Academic Research, by Region, 2019-2032 (USD Million)
6.5. Drug Development & Discovery
- 6.5.1. Global Induced Pluripotent Stem Cell (iPSC) Market, by Drug Development & Discovery, by Region, 2019-2032 (USD Million)
6.6. Toxicity Screening
- 6.6.1. Global Induced Pluripotent Stem Cell (iPSC) Market, by Toxicity Screening, by Region, 2019-2032 (USD Million)
6.7. Regenerative Medicine
- 6.7.1. Global Induced Pluripotent Stem Cell (iPSC) Market, by Regenerative Medicine, by Region, 2019-2032 (USD Million)

7. Global Induced Pluripotent Stem Cell (iPSC) Market, by Workflow

7.1. Key Findings
7.2. Introduction
- 7.2.1. Global Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
7.3. Reprogramming
- 7.3.1. Global Induced Pluripotent Stem Cell (iPSC) Market, by Reprogramming, By Region, 2019-2032 (USD Million)
7.4. Cell Culture
- 7.4.1. Global Induced Pluripotent Stem Cell (iPSC) Market, by Cell Culture, By Region, 2019-2032 (USD Million)
7.5. Cell Characterization / Analysis
- 7.5.1. Global Induced Pluripotent Stem Cell (iPSC) Market, by Cell Characterization / Analysis, By Region, 2019-2032 (USD Million)
7.6. Engineering
- 7.6.1. Global Induced Pluripotent Stem Cell (iPSC) Market, by Engineering, By Region, 2019-2032 (USD Million)
7.7. Others
- 7.7.1. Global Induced Pluripotent Stem Cell (iPSC) Market, by Others, By Region, 2019-2032 (USD Million)

8. Global Induced Pluripotent Stem Cell (iPSC) Market, by Geography

8.1. Key findings
8.2. Introduction
- 8.2.1. Induced Pluripotent Stem Cell (iPSC) Market Assessment, By Geography, 2019-2032 (USD Million)
8.3. Induced Pluripotent Stem Cell (iPSC) Market - North America
- 8.3.1. North America: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
- 8.3.2. North America: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
- 8.3.3. North America: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
- 8.3.4. Induced Pluripotent Stem Cell (iPSC) Market - U.S.
  - 8.3.4.1. U.S.: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
  - 8.3.4.2. U.S.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
  - 8.3.4.3. U.S.: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
- 8.3.5. Induced Pluripotent Stem Cell (iPSC) Market - Canada
  - 8.3.5.1. Canada: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
  - 8.3.5.2. Canada.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
  - 8.3.5.3. Canada: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
8.4. Induced Pluripotent Stem Cell (iPSC) Market - Europe
- 8.4.1. Europe: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
- 8.4.2. Europe.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
- 8.4.3. Europe: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
- 8.4.4. Induced Pluripotent Stem Cell (iPSC) Market - UK
  - 8.4.4.1. UK: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
  - 8.4.4.2. UK.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
  - 8.4.4.3. UK: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
- 8.4.5. Induced Pluripotent Stem Cell (iPSC) Market - France
  - 8.4.5.1. France: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
  - 8.4.5.2. France.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
  - 8.4.5.3. France: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
- 8.4.6. Induced Pluripotent Stem Cell (iPSC) Market - Germany
  - 8.4.6.1. Germany: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
  - 8.4.6.2. Germany.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
  - 8.4.6.3. Germany: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
- 8.4.7. Induced Pluripotent Stem Cell (iPSC) Market - Italy
  - 8.4.7.1. Italy: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
  - 8.4.7.2. Italy.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
  - 8.4.7.3. Italy: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
- 8.4.8. Induced Pluripotent Stem Cell (iPSC) Market - Spain
  - 8.4.8.1. Spain: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
  - 8.4.8.2. Spain.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
  - 8.4.8.3. Spain: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
- 8.4.9. Induced Pluripotent Stem Cell (iPSC) Market - Netherlands
  - 8.4.9.1. Netherlands: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
  - 8.4.9.2. Netherlands.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
  - 8.4.9.3. Netherlands: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
- 8.4.10. Induced Pluripotent Stem Cell (iPSC) Market - Russia
  - 8.4.10.1. Russia: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
  - 8.4.10.2. Russia.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
  - 8.4.10.3. Russia: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
8.5. Induced Pluripotent Stem Cell (iPSC) Market - Asia Pacific
- 8.5.1. Asia Pacific: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
- 8.5.2. Asia Pacific.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
- 8.5.3. Asia Pacific: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
- 8.5.4. Induced Pluripotent Stem Cell (iPSC) Market - China
  - 8.5.4.1. China: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
  - 8.5.4.2. China.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
  - 8.5.4.3. China: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
- 8.5.5. Induced Pluripotent Stem Cell (iPSC) Market - India
  - 8.5.5.1. India: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
  - 8.5.5.2. India.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
  - 8.5.5.3. India: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
- 8.5.6. Induced Pluripotent Stem Cell (iPSC) Market - Malaysia
  - 8.5.6.1. Malaysia: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
  - 8.5.6.2. Malaysia.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
  - 8.5.6.3. Malaysia: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
- 8.5.7. Induced Pluripotent Stem Cell (iPSC) Market - Japan
  - 8.5.7.1. Japan: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
  - 8.5.7.2. Japan.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
  - 8.5.7.3. Japan: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
- 8.5.8. Induced Pluripotent Stem Cell (iPSC) Market - Indonesia
  - 8.5.8.1. Indonesia: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
  - 8.5.8.2. Indonesia.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
  - 8.5.8.3. Indonesia: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
- 8.5.9. Induced Pluripotent Stem Cell (iPSC) Market - South Korea
  - 8.5.9.1. South Korea: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
  - 8.5.9.2. South Korea.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
  - 8.5.9.3. South Korea: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
8.6. Induced Pluripotent Stem Cell (iPSC) Market - Middle East & Africa
- 8.6.1. Middle East & Africa: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
- 8.6.2. Middle East & Africa.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
- 8.6.3. Middle East & Africa: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
- 8.6.4. Induced Pluripotent Stem Cell (iPSC) Market - Saudi Arabia
  - 8.6.4.1. Saudi Arabia: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
  - 8.6.4.2. Saudi Arabia.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
  - 8.6.4.3. Saudi Arabia: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
- 8.6.5. Induced Pluripotent Stem Cell (iPSC) Market - UAE
  - 8.6.5.1. UAE: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
  - 8.6.5.2. UAE.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
  - 8.6.5.3. UAE: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
- 8.6.6. Induced Pluripotent Stem Cell (iPSC) Market - Israel
  - 8.6.6.1. Israel: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
  - 8.6.6.2. Israel.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
  - 8.6.6.3. Israel: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
- 8.6.7. Induced Pluripotent Stem Cell (iPSC) Market - South Africa
  - 8.6.7.1. South Africa: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
  - 8.6.7.2. South Africa.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
  - 8.6.7.3. South Africa: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
8.7. Induced Pluripotent Stem Cell (iPSC) Market - Latin America
- 8.7.1. Latin America: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
- 8.7.2. Latin America.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
- 8.7.3. Latin America: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
- 8.7.4. Induced Pluripotent Stem Cell (iPSC) Market - Mexico
  - 8.7.4.1. Mexico: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
  - 8.7.4.2. Mexico.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
  - 8.7.4.3. Mexico: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
- 8.7.5. Induced Pluripotent Stem Cell (iPSC) Market - Brazil
  - 8.7.5.1. Brazil: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
  - 8.7.5.2. Brazil.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
  - 8.7.5.3. Brazil: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
- 8.7.6. Induced Pluripotent Stem Cell (iPSC) Market - Argentina
  - 8.7.6.1. Argentina: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
  - 8.7.6.2. Argentina.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
  - 8.7.6.3. Argentina: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)

9. Competitive Landscape

9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

10.1. Astellas Pharma Inc
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
10.2. Axol Bioscience Ltd
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
10.3. Cynata Therapeutics Limited
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
10.4. Fate Therapeutics
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
10.5. FUJIFILM Holdings Corporation (Cellular Dynamics)
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
10.6. Ncardia
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
10.7. REPROCELL Inc.
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
10.8. Takara Bio Inc.
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
10.9. Thermo Fisher Scientific Inc.
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
10.10. ViaCyte, Inc
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development

Product Code: PM2014

List of Tables

Table 1 Global Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
Table 2 Global Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
Table 3 Global Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
Table 4 Induced Pluripotent Stem Cell (iPSC) Market Assessment, By Geography, 2019-2032 (USD Million)
Table 5 North America: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
Table 6 North America: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
Table 7 North America: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
Table 8 U.S.: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
Table 9 U.S.: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
Table 10 U.S.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
Table 11 Canada: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
Table 12 Canada: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
Table 13 Canada: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
Table 14 Europe: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
Table 15 Europe: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
Table 16 Europe: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
Table 17 UK: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
Table 18 UK: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
Table 19 UK: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
Table 20 France: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
Table 21 France: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
Table 22 France: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
Table 23 Germany: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
Table 24 Germany: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
Table 25 Germany: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
Table 26 Italy: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
Table 27 Italy: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
Table 28 Italy: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
Table 29 Spain: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
Table 30 Spain: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
Table 31 Spain: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
Table 32 Netherlands: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
Table 33 Netherlands: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
Table 34 Netherlands: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
Table 35 Russia: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
Table 36 Russia: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
Table 37 Russia: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
Table 38 Asia Pacific: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
Table 39 Asia Pacific: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
Table 40 Asia Pacific: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
Table 41 China: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
Table 42 China: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
Table 43 China: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
Table 44 India: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
Table 45 India: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
Table 46 India: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
Table 47 Malaysia: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
Table 48 Malaysia: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
Table 49 Malaysia: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
Table 50 Japan: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
Table 51 Japan: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
Table 52 Japan: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
Table 53 Indonesia: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
Table 54 Indonesia: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
Table 55 Indonesia: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
Table 56 South Korea: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
Table 57 South Korea: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
Table 58 South Korea: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
Table 59 Middle East & Africa: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
Table 60 Middle East & Africa: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
Table 61 Middle East & Africa: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
Table 62 Saudi Arabia: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
Table 63 Saudi Arabia: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
Table 64 Saudi Arabia: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
Table 65 UAE: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
Table 66 UAE: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
Table 67 UAE: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
Table 68 Israel: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
Table 69 Israel: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
Table 70 Israel: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
Table 71 South Africa: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
Table 72 South Africa: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
Table 73 South Africa: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
Table 74 Latin America: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
Table 75 Latin America: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
Table 76 Latin America: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
Table 77 Mexico: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
Table 78 Mexico: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
Table 79 Mexico: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
Table 80 Brazil: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
Table 81 Brazil: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
Table 82 Brazil: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
Table 83 Argentina: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
Table 84 Argentina: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
Table 85 Argentina: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)

List of Figures

Figure 1. Global Induced Pluripotent Stem Cell (iPSC) Market, 2019-2032 (USD Million)
Figure 2. Integrated Ecosystem
Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
Figure 4. Market by Geography
Figure 5. Porter's Five Forces
Figure 6. Market by Application
Figure 7. Global Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2022 & 2032 (USD Million)
Figure 8. Market by Derived Cell
Figure 9. Global Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2022 & 2032 (USD Million)
Figure 10. Market by Workflow
Figure 11. Global Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2022 & 2032 (USD Million)
Figure 12. Induced Pluripotent Stem Cell (iPSC) Market Assessment, By Geography, 2019-2032 (USD Million)
Figure 13. Strategic Analysis - Induced Pluripotent Stem Cell (iPSC) Market

Induced Pluripotent Stem Cell Market Share, Size, Trends, Industry Analysis Report, By Derived Cell; By Workflow; By Application; By Region; Segment Forecast, 2024 - 2032

Description

Table of Contents

List of Tables

iPSC Market Report Highlights

iPSC, Derived Cell Outlook (Revenue - USD Million, 2019 - 2032)

iPSC, Workflow Outlook (Revenue - USD Million, 2019 - 2032)

iPSC, Application Outlook (Revenue - USD Million, 2019 - 2032)

iPSC, Regional Outlook (Revenue - USD Million, 2019 - 2032)

Table of Contents

1. Introduction

2. Executive Summary

3. Research Methodology

4. Global Induced Pluripotent Stem Cell (iPSC) Market Insights

5. Global Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell

6. Global Induced Pluripotent Stem Cell (iPSC) Market, by Application

7. Global Induced Pluripotent Stem Cell (iPSC) Market, by Workflow

8. Global Induced Pluripotent Stem Cell (iPSC) Market, by Geography

9. Competitive Landscape

10. Company Profiles

List of Tables

List of Figures